Framingham Heart Study, Internal medicine, Framingham Risk Score, Dementia and Stroke are her primary areas of study. Her study in Framingham Heart Study is interdisciplinary in nature, drawing from both Alzheimer's disease, Cohort and Risk factor. Her Internal medicine research is multidisciplinary, relying on both Diabetes mellitus, Middle temporal gyrus and Cardiology.
The various areas that she examines in her Framingham Risk Score study include Developmental psychology, Verbal memory and Cohort study. Her studies in Dementia integrate themes in fields like Gerontology, Psychiatry, Cognition, Prospective cohort study and Physical therapy. Her Stroke research incorporates themes from Hyperintensity, Epidemiology, Pathology, Surgery and Diffusion MRI.
Her primary areas of study are Framingham Heart Study, Internal medicine, Dementia, Framingham Risk Score and Stroke. Her studies deal with areas such as Cohort study, Neuropsychology, Gerontology, Cohort and Risk factor as well as Framingham Heart Study. Her Internal medicine research includes elements of Pathology, Endocrinology, Brain size and Cardiology.
Her biological study spans a wide range of topics, including Psychiatry, Cognition, Cognitive impairment and Hazard ratio. Her work deals with themes such as Developmental psychology, Body mass index, Surgery and Cognitive decline, which intersect with Framingham Risk Score. Rhoda Au usually deals with Stroke and limits it to topics linked to Hyperintensity and Brain ischemia.
Rhoda Au focuses on Framingham Heart Study, Dementia, Neuropsychology, Disease and Internal medicine. Her Framingham Heart Study research is multidisciplinary, incorporating elements of Epidemiology, Proportional hazards model, Cohort study and Cohort. Her research integrates issues of Neuropsychological test, Risk factor, Gerontology and Cognitive impairment in her study of Dementia.
Her Neuropsychology research is multidisciplinary, incorporating perspectives in Vascular dementia, Clinical psychology, Brain behavior and Audiology. Rhoda Au has researched Internal medicine in several fields, including Hyperintensity, Oncology and Cardiology. She focuses mostly in the field of Framingham Risk Score, narrowing it down to matters related to Stroke and, in some cases, Quartile.
Her primary areas of study are Dementia, Framingham Heart Study, Disease, Internal medicine and Cohort. Her Dementia research integrates issues from Neuroscience, Neuropsychology and Artificial intelligence. Her Framingham Heart Study study improves the overall literature in Framingham Risk Score.
As part of her studies on Internal medicine, Rhoda Au often connects relevant areas like Depression. Her Cohort study combines topics from a wide range of disciplines, such as Cognitive impairment and Test set. Her Alzheimer's disease study incorporates themes from Interquartile range and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide analysis of genetic loci associated with Alzheimer disease.
Sudha Seshadri;Annette L. Fitzpatrick;M Arfan Ikram;Anita L. DeStefano.
The Lifetime Risk of Stroke Estimates From the Framingham Study
Sudha Seshadri;Alexa Beiser;Margaret Kelly-Hayes;Carlos S. Kase.
The Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort
Merrill F. Elias;Alexa Beiser;Philip A. Wolf;Rhoda Au.
JAMA Neurology (2000)
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
Ernst J. Schaefer;Vanina Bongard;Alexa S. Beiser;Stefania Lamon-Fava.
JAMA Neurology (2006)
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
S. Debette;S. Seshadri;S. Seshadri;A. Beiser;A. Beiser;R. Au;R. Au.
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal
Charles DeCarli;Joseph Massaro;Danielle J Harvey;John Hald.
Neurobiology of Aging (2005)
Depressive symptoms and risk of dementia: the Framingham Heart Study
Jane S. Saczynski;Alexa Beiser;Sudha Seshadri;S. Auerbach.
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Z. S. Tan;A. S. Beiser;R. S. Vasan;R. Roubenoff.
Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
Wolfgang Lieb;Alexa S. Beiser;Alexa S. Beiser;Ramachandran S. Vasan;Ramachandran S. Vasan;Zaldy S. Tan.
Apolipoprotein E element 4 association with dementia in a population-based study The Framingham Study
R. H. Myers;E. J. Schaefer;P.W.F. Wilson;R. D'Agostino.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: